- Home
- GCTS vs INO Comparison
GCTS vs INO Comparison
Compare GCTS & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCTS
- INO
- Stock Information
- Founded
- GCTS 1998
- INO 1979
- Country
- GCTS United States
- INO United States
- Employees
- GCTS N/A
- INO N/A
- Industry
- GCTS Blank Checks
- INO Medical/Dental Instruments
- Sector
- GCTS Finance
- INO Health Care
- Exchange
- GCTS Nasdaq
- INO Nasdaq
- Market Cap
- GCTS 82.5M
- INO 69.3M
- IPO Year
- GCTS N/A
- INO 1998
- Fundamental
- Price
- GCTS $1.54
- INO $1.47
- Analyst Decision
- GCTS Strong Buy
- INO Buy
- Analyst Count
- GCTS 1
- INO 5
- Target Price
- GCTS $5.00
- INO $8.80
- AVG Volume (30 Days)
- GCTS 337.9K
- INO 3.5M
- Earning Date
- GCTS 08-13-2025
- INO 08-07-2025
- Dividend Yield
- GCTS N/A
- INO N/A
- EPS Growth
- GCTS N/A
- INO N/A
- EPS
- GCTS N/A
- INO N/A
- Revenue
- GCTS $6,359,000.00
- INO $283,099.00
- Revenue This Year
- GCTS $133.55
- INO N/A
- Revenue Next Year
- GCTS $347.37
- INO $20,588.06
- P/E Ratio
- GCTS N/A
- INO N/A
- Revenue Growth
- GCTS N/A
- INO N/A
- 52 Week Low
- GCTS $0.90
- INO $1.30
- 52 Week High
- GCTS $5.01
- INO $12.33
- Technical
- Relative Strength Index (RSI)
- GCTS 57.29
- INO 42.04
- Support Level
- GCTS $1.32
- INO $1.30
- Resistance Level
- GCTS $1.69
- INO $1.60
- Average True Range (ATR)
- GCTS 0.09
- INO 0.08
- MACD
- GCTS 0.01
- INO 0.02
- Stochastic Oscillator
- GCTS 62.50
- INO 56.67
About GCTS GCT Semiconductor Holding Inc. Common Stock
GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.